Kristen Galfetti
Plus aucun poste en cours
Fortune : 1 896 $ au 31/03/2024
Profil
Kristen Galfetti formerly worked at Genzyme Corp., as Director-Investor Relations, Sanofi, as Senior Director-Investor Relations, National Investor Relations Institute, as Director, AMAG Pharmaceuticals, Inc., as Senior Director-Investor Relations, Cynapsus Therapeutics, Inc., as VP-Investor Relations & Corporate Communications, and Titan Medical, Inc., as VP-Investor Relations & Corporate Communications from 2021 to 2023.
Ms. Galfetti received her Masters Business Admin degree from Bentley University and undergraduate degree from the University of Vermont.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
TITAN MEDICAL INC.
0,03% | 16/12/2022 | 36 454 ( 0,03% ) | 1 896 $ | 31/03/2024 |
Anciens postes connus de Kristen Galfetti
Sociétés | Poste | Fin |
---|---|---|
TITAN MEDICAL INC. | Investor Relations Contact | 08/02/2023 |
SANOFI | Investor Relations Contact | 02/01/1910 |
CYNAPSUS THERAPEUTICS INC | Investor Relations Contact | - |
AMAG PHARMACEUTICALS, INC. | Public Communications Contact | - |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Director/Board Member | - |
Formation de Kristen Galfetti
Bentley University | Masters Business Admin |
University of Vermont | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SANOFI | Health Technology |
TITAN MEDICAL INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Cynapsus Therapeutics, Inc.
Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |